Stockreport

Spring Bank Advances IV SB 11285 Clinical Program

SPRING BANK PHARMACEUTICALS  (SBPH) 
Last spring bank pharmaceuticals earnings: 11/7 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.springbankpharm.com/investor-overview
PDF -    Safety Review Committee for IV SB 11285 Phase 1a/1b trial recommends dose escalation to next planned monotherapy dose level and initiation of first co-administratio [Read more]